Complex Regional Pain Syndrome Clinical Trial
Official title:
Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
The aim of this trial was to investigate the safety of intravenous neridronic acid in
patients with complex regional pain syndrome (CRPS).
The trial was divided into 3 periods: a 60-day enrollment period, a treatment period
consisting of 4 infusions over 10 days, and a follow-up period of approximately 50 weeks
(with visits at Week 2, Week 6, Week 12, Week 26, Week 39, and Week 52).
At the Enrollment Visit the trial objectives, procedures, and risks were explained to the
participants and the informed consent form was signed. Medical history was obtained, a
physical examination was conducted, and other safety assessments were performed. Signs and
symptoms of CRPS were assessed to confirm the diagnosis of CRPS according to the Budapest
clinical criteria. Participants were trained to report their pain. Calcium and vitamin D
supplementation were initiated to ensure sufficient vitamin D levels prior to treatment.
Participants meeting all eligibility criteria received infusions of investigational medicinal
product (IMP) during visits on Day 1, Day 4, Day 7, and Day 10. Flexibility of ±1 day was
allowed for Day 4, Day 7, and Day 10 whilst ensuring a minimum period of 48 hours between
infusions. During the treatment period and follow-up period, pain intensity ratings were
captured at the site visits in a patient reported-outcome system.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02753335 -
A Comparison of Two Treatments for CRPS and Changes in Resting-State Connectivity of Cerebral Networks.
|
N/A | |
| Recruiting |
NCT01134289 -
Analysis of Photoplethysmographic Signal in Lumbar Sympathetic Block
|
Phase 3 | |
| Completed |
NCT00579085 -
Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
|
Phase 2 | |
| Completed |
NCT02837822 -
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
|
N/A | |
| Completed |
NCT02070367 -
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)
|
N/A | |
| Completed |
NCT00462566 -
The Efficacy of Motor Cortex Stimulation for Pain Control
|
N/A | |
| Active, not recruiting |
NCT03228160 -
Light Irradiation and Outcome for Neuropathic Pain
|
N/A | |
| Terminated |
NCT02094352 -
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
|
Phase 2 | |
| Recruiting |
NCT02502162 -
Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
|
N/A | |
| Completed |
NCT03990649 -
Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)
|
Phase 2 | |
| Recruiting |
NCT03616262 -
"Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome"
|
Early Phase 1 | |
| Active, not recruiting |
NCT02504008 -
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
|
Phase 3 | |
| Completed |
NCT03879538 -
Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome
|
Phase 3 | |
| Terminated |
NCT03794024 -
Comparison of Dorsal Column Stimulation to Dorsal Root Ganglion Stimulation for Complex Regional Pain Syndrome
|
||
| Terminated |
NCT00780390 -
Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome
|
N/A | |
| Completed |
NCT00904202 -
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
|
Phase 4 | |
| Recruiting |
NCT05197959 -
Treatment of Complex Regional Pain Syndrome
|
N/A | |
| Completed |
NCT02753101 -
[18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica
|
Early Phase 1 | |
| Withdrawn |
NCT00414804 -
Spinal Cord Stimulation Versus Nerve Blocks and Physical Therapy
|
N/A | |
| Not yet recruiting |
NCT06306157 -
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
|
Phase 4 |